Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Adocia    ADOC   FR0011184241

ADOCIA (ADOC)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Adocia
Provides research and development services to the biotechnology field

Adocia SA is a biotechnology company that specializes in the development of medicines from already approved therapeutic agents.

It is also engaged in the research and development of biotheraphy products used in tissue regeneration and for treating chronic diseases.

Its products include pipeline, PDGF-BB, BioChaperone insulins combo based on Glargine, BioChaperone ultra-fast analog insulin, HinsBet, monoclonal antibodies formulations, and DriveIn-Dox.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.


Number of employees : 80 persons.
Sales per Businesses
20132014Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine5.59100%0.704100% -693.75%
Sales per Regions
20132014Delta
EUR (in Million)%EUR (in Million)%
France5.59100%0.704100% -693.75%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA682005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006CFO, Principal Financial & Accounting Officer
Olivier Soula PhD, MBA472005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA46-Director
Laurent Arthaud54-Director
Dominique Takizawa592011Independent Director
Jérôme Féraud41-Director
Ekaterina Smirnyagina, PhD502013Independent Director
Rémi Soula, PhD-2005Director-Business Development
José Correia, PhD--Director-Preclinical & Clinical Department
Shareholders
NameEquities%
BPIFrance Investissement SAS 903,269 13.2%
Gérard Soula PhD, MBA 898,463 13.1%
La Société Hospitalière d'Assurances Mutuelles SA 320,000 4.68%
Olivier Soula PhD, MBA 317,490 4.64%
Rémi Soula, PhD 317,490 4.64%
Alken Asset Management Ltd. 193,799 2.83%
Oddo Meriten Asset Management SA 193,731 2.83%
Groupe des Assurances du Crédit Mutuel SA 125,944 1.84%
ACG Management SAS 95,712 1.40%
Oreo Finance SAS 81,561 1.19%
Holdings
NameEquities%Valuation
Adocia (ADOC) 1,3770.020%109,525 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
CELGENE CORPORATI..
REGENERON PHARMAC..
VERTEX PHARMACEUT..
SHANGHAI RAAS BLO..
-
ACTELION LTD
GENMAB A/S
MEDIVATION INC
TONGHUA DONGBAO P..
HUALAN BIOLOGICAL..
CHINA BIOLOGIC PR..
NEUROCRINE BIOSCI..
3SBIO INC
-
JUNO THERAPEUTICS..
BEIJING SL PHARMA..
INTERCEPT PHARMAC..
ZHONGYUAN UNION C..
VIROMED CO LTD
-
ULTRAGENYX PHARMA..
-
Sector Biotechnology & Medical Research
Adocia : Connections
DIEAU-EDAFIM SA
Alizé Pharma SAS
Axess Vision Technology SA
Biom'Up SA
Lyon Place Financière & Tertiaire
BPIFrance Investissement SAS
FAB Pharma SAS
Laboratoire Precilens SA
Mérieux NutriSciences Corp.
ACG Management SAS
Institut Mérieux SA
iSTAR Medical SA
Lyon Pôle Bourse
Capricorn Venture Partners NV
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid 60, CAC Mid Small, CAC PME, EnterNext© PEA-PME 150, Next 150, Next Biotech, PEA-PME, SBF 120, Tech 40
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem